|
Re: Interesting read on the backlash to FDA's approval of aducanumab
|
4
|
Resverlogix Corp.
|
Jun 11, 2021 06:46AM
|
|
Re: Interesting Trades / Volume .....
|
3
|
Resverlogix Corp.
|
Jan 27, 2019 05:57AM
|
|
Re: Interesting Trades / Volume .....
|
5
|
Resverlogix Corp.
|
Jan 26, 2019 05:10AM
|
|
Re: interesting trading on Friday May 7/2021
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 10, 2021 11:40AM
|
|
Re: Interesting.
|
6
|
Resverlogix Corp.
|
Nov 23, 2021 11:13AM
|
|
Re: Interesting.
|
1
|
Resverlogix Corp.
|
Nov 23, 2021 04:59PM
|
|
Re: Interesting.
|
5
|
Resverlogix Corp.
|
Nov 24, 2021 11:44AM
|
|
Re: Interim Analysis
|
2
|
Resverlogix Corp.
|
Oct 16, 2020 09:58AM
|
|
Re: Inventory and Revenue calcs
|
1
|
Resverlogix Corp.
|
May 13, 2021 11:42AM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
2
|
Resverlogix Corp.
|
Jun 08, 2020 06:02PM
|
|
Re: IP considerations may prevent RVX from disclosing eGFR data
|
2
|
Resverlogix Corp.
|
Jun 08, 2020 06:38PM
|
|
Re: IR
|
3
|
Resverlogix Corp.
|
Jan 14, 2023 10:08AM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 10, 2023 09:13AM
|
|
Re: IR
|
1
|
Resverlogix Corp.
|
Jan 18, 2023 06:16AM
|
|
Re: IR
|
2
|
Resverlogix Corp.
|
Jan 18, 2023 08:18AM
|
|
Re: IR - "but all I can tell you at the moment is that we believe we are making real progress towards achieving our goals."
|
2
|
Resverlogix Corp.
|
May 14, 2023 09:35AM
|
|
Re: IR response
|
3
|
Resverlogix Corp.
|
May 06, 2022 10:15AM
|
|
Re: IR response
|
1
|
Resverlogix Corp.
|
May 06, 2022 10:35AM
|
|
Re: IR response
|
1
|
Resverlogix Corp.
|
May 06, 2022 10:31PM
|
|
Re: IR response
|
4
|
Resverlogix Corp.
|
Jan 12, 2022 07:55AM
|
